IDMED is a French company based in Marseille that specializes in developing and marketing innovative medical devices in the fields of anesthesia and intensive care. The company, founded in 2008, has a strong focus on producing products used worldwide in operating theaters, intensive care units, neuro-ophthalmological consultations, and research laboratories. IDMED's product range encompasses areas such as pupillometry, neuromuscular blockade monitoring, and analgesia monitoring. The company takes pride in its close collaboration with healthcare professionals to ensure that innovation, reliability, and relevance are the core qualities of their devices. IDMED's commitment to putting technical knowledge at the service of an improved everyday clinical practice is reflected in their slogan: "Innovative technology, safer outcomes." With a firm foothold in the manufacturing, medical devices, and marketing industries, the company is positioned as an attractive prospect for potential investors looking to support advancements in medical technology.
There is no investment information
No recent news or press coverage available for IDMED.